Detailed Findings

Dealmaking in 2025

A comeback for deals in 2025?

2024 was slow to demonstrate a recovery in dealmaking, as a result of geopolitical tensions and a higher-for-longer interest rate environment – but  it is finally picking up. This optimism is demonstrated in the 72% of respondents who think M&A will be higher next year than this year, with Institutional Investors and Corporates more bullish versus last year. 

Very few (4%) think it will be lower than last year, in a further sign of respondents signalling that we are over the worst of market conditions and that there is appetite to get deals done.   

0%

Where do you expect Healthcare M&A activity levels to be in 2025 compared to 2024?

Where do you expect Healthcare M&A activity levels to be in 2025 compared to 2024?
All (2022)All (2023)All (2024)Institutional InvestorPrivate Equity InvestorHealthcare Corporate Representative
Higher636872646675
About the same242622273119
Lower1254534
Do not know122502

IMPORTANT: You must read the following before reading, accessing or making any other use of this publication. In accessing this publication, you agree to be bound by the following terms and conditions. This document is being furnished for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to purchase any security or other financial instrument or product. It is not intended to form the basis of any investment decision. Jefferies International Limited and its affiliates (together “Jefferies”) makes no representation as to the accuracy or completeness of the information contained herein or any other information, whether written or oral, made available. Jefferies disclaims all and any liability whatsoever, whether arising in tort, contract or otherwise, for the contents of this publication. You acknowledge that Jefferies does not owe you or any other person or entity, any fiduciary or similar duty as a result of the publication of this report, and Jefferies is not providing any advice, including with respect to legal, tax, accounting, investment or regulatory matters, in any jurisdiction.